Advertisement

Search Results for "Confusion In Advanced Cancer Patients"

22:34 EDT 23rd May 2013 | BioPortfolio

Original Source: Delirium Recall in Advanced Cancer Patients

Primary Objectives: 1. To determine the proportion of patients who experience partial or complete recollection of symptoms of delirium and the level of distress associated with this recall. 2. To determine caregiver's level of distress associated with the patient's episode of delirium.

Matching Channels

Prostate Cancer

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

Brain Cancer

According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain...

UroGenRA - Genitourinary cancer array

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It...

ImmTAC

Immunocore’s ImmTAC technology enables the immune system to recognise and kill cancer or viral cells. T Cell Receptors naturally recognise diseased cells and Immunocore’s competitive ad...

Kadcyla (ado-trastuzumab emtansine)

Kadcyla™ (ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin® (trastuzumab)...

Matching News

Confusion Helps Us Learn

When we’re confused by something--say with a movie plot or calculus--we tend to feel uncomfortable, frustrated. But maybe we should embrace the confusion. Because a new study finds that confusio...

Study Finds Advanced Cancer Patients Overoptimistic About Chemotherapy's Ability To Cure

Findings from a nationwide study led by researchers at Dana-Farber Cancer Institute suggest that patients with advanced lung or colorectal cancer are frequently mistaken in their beliefs that chemothe...

Safety group forewarned about Genentech drug name confusion

Long before the FDA warned on 6 May about the risk of name confusion for two Genentech breast cancer drugs, the Institute for Safe Medications Practices (ISMP) was on the case, alerting health care...

Dana-Farber study finds advanced cancer patients overoptimistic about chemotherapy's ability to cure

Findings from a nationwide study led by researchers at Dana-Farber Cancer Institute suggest that patients with advanced lung or colorectal cancer are frequently mistaken in their beliefs that chemothe...

The Confusion Over A Pair Of Diabetes Drugs And Pancreatitis

A new study suggests two widely used diabetes drugs increase the risk of pancreatitis. Although the analysis was quickly dismissed by some analysts and physician groups, the findings still have the po...

Confusion is everywhere

Confusion abounds. The recent BMJ discussion about screening for dementia highlighted that it is incorrect and potentially stigmatising to consider such confusion as the preserve of the older...

Mayo Clinic urologists recommend personalized approach for prostate cancer screening

There is a lot of conflicting advice about prostate cancer screening. A recent U.S. Preventative Services Task Force recommendation against prostate-specific antigen testing, regardless of age, has ad...

Married patients with locally advanced lung cancer likely to survive longer after treatment

Married patients with locally advanced lung cancer are likely to survive longer after treatment than patients who are single, according to a study by researchers at the University of Maryland Marlene...

Matching PubMed Articles

Is discussion of colorectal cancer screening options associated with heightened patient confusion?

BACKGROUND: Clinical guidelines recommend offering patients options for colorectal cancer (CRC) screening, but the modalities vary by frequency, accuracy, preparations, discomfort and cost, which may...

Does gender influence outcomes from a multidisciplinary intervention for quality of life designed for patients with advanced cancer?

PURPOSE: Cancer treatment can profoundly impact the patient's quality of life (QOL). It has been well documented that there are gender differences in the symptoms associated with cancer treatment. Thi...

Confusion and Neo-Confusion: Corrole Isomers with an NNNC Core.

Impact of a Family History of Colorectal Cancer on the Prevalence of Advanced Neoplasia at Colonoscopy in 4,967 Asymptomatic Patients.

BACKGROUND AND AIMS: A family history of colorectal cancer is considered an independent risk factor for advanced neoplasia at colonoscopy. The expected outcome for screening colo...

The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients.

PURPOSE: Depression is highly prevalent in advanced cancer patients, but the diagnosis of depressive disorder in patients with advanced cancer is difficult. Screening instruments could facilitate diag...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement